|
| |
 |
L-CARNITINE
L-CARNITINE is a vitamin-like nutrient related
to vitamins of the B-group (vitamin BT).
L-CARNITINE is a physiological
substance, essential for energy production and for fat metabolism.
L-CARNITINE is not an amino acid in the
strict sense (it is not used as a neurotransmitter or in protein synthesis),
however it bears many resemblances to amino acids and is usually grouped under
this heading. L-CARNITINE (the "L" refers to
its chemical polarity) is used by the body to transport long chain fatty acids
to the mitochondria in your cells, where it is burned for energy. Since this fat
burning is such a major source of muscular energy, deficiencies in L-CARNITINE
are manifested as low energy levels and muscular weakness. They
can also appear as mental confusion or cloudiness, angina (heart pain) and
weight gain.
Directions: Take
1-3 capsules per day or as recommended by a health care professional. Pure
L-Carnitine should be taken with vitamins and minerals. Tyson's
MVM (Multivitamin) is highly recommended.
|
Key Benefits
Pricing
|
Description |
SKU # |
Size |
Price |
Purchase |
|
00670
|
NDC 53335-055-10
|
30 Caps (250 mg)
|
$ 22.00
|
|
References
- 209) Arenas J, Ricoy JR, Encinas AR, Pola P, D'Iddio S, Zeviani M, Didonato S,
Corsi M. Carnitine in muscle, serum, and urine of nonprofessional athletes:
effects of physical exercise, training, and L-carnitine administration. Muscle
Nerve 1991 Jul;14(7):598-604
- 210) Nuesch R, Rossetto M, Martina B. Plasma and urine carnitine concentrations
in well-trained athletes at rest and after exercise. Influence of L-carnitine
intake. Drugs Exp Clin Res 1999;25(4):167-71. 211) Malone JI, Schocken DD, Morrison AD, Gilbert-Barness E. Diabetic
cardiomyopathy and carnitine deficiency. J Diabetes Complications 1999
Mar-Apr;13(2):86-90.
- 212) K L Goa and R N Brogden. L-carnitine--a preliminary review of its
pharmacokinetics, and its therapeutic use in ischemic cardiac disease and
primary and secondary carnitine deficiencies in relationship to its role in
fatty acid metabolism. Drugs 34 1987:1-24.
- 213) M Mancini et al. Controlled study on the therapeutic efficacy of
propionyl-L-carnitine in patients with congestive heart failure. Arzneim
Forsch 42 1992:1101-4.
- 214) Cacciatore L, Cerio R, Ciarimboli M, Cocozza M, Coto V, D'Alessandro A,
D'Alessandro L, Grattarola G, Imparato L, Lingetti M, et al. The therapeutic
effect of L-carnitine in patients with exercise-induced stable angina: a
controlled study. Drugs Exp Clin Res 1991;17(4):225-35.
- 215) Bartels GL, Remme WJ, Pillay M, Schonfeld DH, Kruijssen DA. Effects of L-propionylcarnitine
on ischemia-induced myocardial dysfunction in men with angina pectoris. Am J
Cardiol 1994 Jul 15;74(2):125-30.
- 216) Kamikawa T, Suzuki Y, Kobayashi A, Hayashi H, Masumura Y, Nishihara K, Abe
M, Yamazaki N. Effects of L-carnitine on exercise tolerance in patients with
stable angina pectoris. Jpn Heart J 1984 Jul;25(4):587-97.
- 217) Cherchi A, Lai C, Angelino F, Trucco G, Caponnetto S, Mereto PE, Rosolen
G, Manzoli U, Schiavoni G, Reale A, et al. Effects of L-carnitine on exercise
tolerance in chronic stable angina: a multicenter, double-blind, randomized,
placebo controlled crossover study. Int J Clin Pharmacol Ther Toxicol 1985
Oct;23(10):569-72.
- 218) Bartels GL, Remme WJ, Holwerda KJ, Kruijssen DA. Anti-ischaemic efficacy
of L-propionylcarnitine--a promising novel metabolic approach to ischaemia?
Eur Heart J 1996 Mar;17(3):414-20
-
185) Goodliffe, C. How to Avoid Heart Disease. Blandford Press, Poole, 1987
- 199) Simone, c. et al. Vitamins and immunity: influence of carnitine on immune system, Acta Vitaminologica Enzymologica, 4 (1-2): 135-40
|
